Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
about
Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysisA meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weightThe Quebec Pregnancy Cohort--prevalence of medication use during gestation and pregnancy outcomesIncreased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data.Antidepressant use in pregnancy and the risk of cardiac defectsMaternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung's disease in newborns - a nationwide cohort study.Antenatal maternal emotional distress and duration of pregnancyLinks between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.Can nonrandomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs?Pregnant women with posttraumatic stress disorder and risk of preterm birthAntidepressant use in pregnant and postpartum womenTreatment of nonpsychotic major depression during pregnancy: patient safety and challengesEarly pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis.Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.Prenatal depression and adverse birth outcomes: an updated systematic review.Effects of Citalopram on Sutural and Calvarial Cell Processes.Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblingsSelective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort StudiesMaternal psychiatric disorders and risk of preterm birthThe risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.Placental serotonin: implications for the developmental effects of SSRIs and maternal depressionSelective serotonin reuptake inhibitors and pregnancy: A review of maternal, fetal and neonatal risks and benefits.Antidepressant exposure in pregnancy and risk of autism spectrum disorders.Effects of maternal psychotropic drug dosage on birth outcomes.Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies.Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.Prenatal SSRI exposure: Effects on later child development.First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies.Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies.Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies.Selective Serotonin Reuptake Inhibitors as First-Line Antidepressant Therapy for Perinatal Depression.Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes.Prenatal exposure to antidepressants and risk of epilepsy in childhood.Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.Patterns and factors associated with low adherence to psychotropic medications during pregnancy--a cross-sectional, multinational web-based study.Meta-analysis requires independent observations and freedom from bias.
P2860
Q21198704-025B6058-412E-4469-9078-0DDC69240485Q24623163-86F1A29B-8082-4CE0-9DAC-2A330F3A20F6Q28542006-0B1EC8EF-9A72-4938-96E8-53F5661A99B8Q30855293-4843C0D3-11D0-4434-AC86-E4513CB02891Q33775616-E4FA523E-D6A8-4237-ABF9-298D2BB212D8Q33816388-6A402268-927B-483D-9D07-450299AA7DE5Q33856280-3227BE7A-689D-4C5D-A1DE-D132B032940AQ34047430-8A26D6C3-A291-46EB-913B-7FAB2963B691Q34049650-67CE78C2-8B87-4E78-A280-11DA7353FB71Q34053512-B40F2F42-53C2-42E2-8297-3B53D4D70CEAQ34068023-1A205B60-4634-401D-9746-CAD3989D6026Q34237681-C707BF5B-A2E1-43F6-A3FE-33E6B130E401Q34483257-791100B2-4A3D-4FE2-A1E3-586C0D3CA77AQ35132422-76530120-7AA4-470F-BABF-C6A880079905Q35541040-BC679463-6D0B-4B87-B74E-14E64205630BQ35661005-9C8FBAAB-D727-465B-9126-74631C998CF0Q35796871-1482D10F-F292-479C-936D-9FC799739C0BQ36107667-91F40A26-AE74-4DAA-9A3C-E656D899A59DQ36141324-C8E72744-BE31-41C1-881E-647F6E56694CQ36396118-2CA217F0-E7B5-4F4F-83A8-9D8FB2E819CBQ36706789-4391AB40-FDEF-4ECB-BC20-F297ABD695CEQ36785491-B580B706-4E43-4285-9973-DA03DBD010ECQ37216136-BA0B84A0-B1AB-4505-AC7D-5BAE667D56BEQ37320948-84F9CBEA-E1A2-413B-89E9-7AC509379E57Q37397151-38318D32-CF89-4FA5-B6F6-E05D184A1D03Q37612128-D61837C7-5DD6-4A0C-8F2D-E104359C90BBQ37654878-FC2376C2-8FDA-4CBF-AA59-A06AA12E2B0FQ38089714-CF6451B4-D80B-4C32-97F8-680AED156AC7Q38236646-9131D94D-D15B-49F1-9973-FC0A75AE526CQ38599005-3531202E-9CA3-4036-9166-9F775637CE71Q38672603-D32509CB-5536-44AF-8AF6-966189ED71E7Q38781285-CEC5FDAB-C28E-488E-A0D4-4BABE1183E14Q38823790-9839C10D-7BBE-48AC-949D-A13F70CFA623Q38988107-121906F3-076B-4649-8263-57742186E109Q39293315-A55CA5B5-FD61-46BA-B5CE-787EBE3A69CFQ40043224-A8F11698-8C54-4146-B666-AE0D9D5834B2Q40498883-77631B4F-5952-4788-8C47-D8F438EAA07EQ40764468-0EC11B11-838C-43BA-8EF0-4A8F01893A50Q41374090-C2C57CC3-6ABC-402D-B4E2-FE645242F2ACQ42770388-F6694141-D3EA-4B1B-9C88-844F98DDE136
P2860
Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Pregnancy outcome after exposu ...... Mother and Child Cohort Study.
@en
Pregnancy outcome after exposu ...... Mother and Child Cohort Study.
@nl
type
label
Pregnancy outcome after exposu ...... Mother and Child Cohort Study.
@en
Pregnancy outcome after exposu ...... Mother and Child Cohort Study.
@nl
prefLabel
Pregnancy outcome after exposu ...... Mother and Child Cohort Study.
@en
Pregnancy outcome after exposu ...... Mother and Child Cohort Study.
@nl
P2093
P50
P1476
Pregnancy outcome after exposu ...... Mother and Child Cohort Study.
@en
P2093
Gideon Koren
Malin Eberhard-Gran
Marleen M H J van Gelder
P304
P356
10.1097/JCP.0B013E3182490EAF
P407
P577
2012-04-01T00:00:00Z